Also trades as: 3933.HK (HKSE) · $vol 7M
ULIHF OTC
The United Laboratories International Holdings Limited
1W: +5.9%
1M: -2.7%
3M: +14.8%
YTD: -42.5%
1Y: -52.6%
3Y: +42.9%
5Y: +70.2%
$1.07
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$3.2B
+31.1% ▲
5Y CAGR: +12.2%
Capital Expenditures
$1.9B
-27.9% ▼
5Y CAGR: +34.1%
Free Cash Flow
$1.3B
+36.0% ▲
5Y CAGR: -0.6%
Dividends Paid
$1.0B
-75.0% ▼
Buybacks
$36M
+0.0% ▲
Net Change in Cash
$2.1B
+529.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $703M | $988M | $1.6B | $3.3B | $3.3B |
| Depreciation & Amort. | $605M | $607M | $535M | $566M | $616M |
| Stock-Based Comp. | $0 | $0 | $0 | $6M | $47M |
| Change in Working Capital | -$359M | -$1.4B | -$550M | -$905M | $115M |
| Other Non-Cash Items | $619M | $1.4B | $465M | -$572M | -$867M |
| Operating Cash Flow | $1.6B | $1.5B | $2.0B | $2.4B | $3.2B |
| — Investing Activities — | |||||
| Capital Expenditures | -$531M | -$482M | -$780M | -$1.3B | -$1.8B |
| Acquisitions (Net) | $0 | $0 | -$7M | $0 | $0 |
| Investment Purchases | $0 | $0 | -$1.7B | -$2.4B | -$20.8B |
| Investment Sales | $0 | $0 | $1.7B | $2.4B | $20.9B |
| Other Investing | $698M | -$105M | $174M | -$355M | -$20M |
| Investing Cash Flow | $167M | -$587M | -$595M | -$1.6B | -$1.7B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$1.7B | -$318M | $328M | -$739M | $1.6B |
| Stock Repurchased | $4.1B | -$41M | -$42M | $0 | -$36M |
| Dividends Paid | -$128M | -$221M | -$273M | -$581M | -$1.0B |
| Other Financing | -$123M | -$41M | -$38M | -$42M | $9M |
| Financing Cash Flow | -$1.9B | -$621M | -$24M | -$1.4B | $597M |
| Net Change in Cash | -$168M | $334M | $1.4B | -$481M | $2.1B |
| Cash End of Period | $3.0B | $3.3B | $4.7B | $4.3B | $6.3B |
| Free Cash Flow | $1.0B | $1.1B | $1.3B | $978M | $1.3B |